Geneuity provides innovative specialized laboratory testing for preclinical through Phase lV clinical trials to promote the safety and efficacy of experimental therapeutics and new diagnostic assays. Geneuity has expertise in genomics, custom assay design, method development and validation. We provide scientific & clinical consultation to pharmaceutical and diagnostics companies as well CROs and IVD kit manufacturers. Geneuity maintains a complete catalogue of analytically validated assays for DNA/RNA, biomarker, and proteomic analyses including multiplex PCR, gene expression, cytokine/protein multiplexing, ELISA/immunoassays, DNA sequencing, MDx, flow cytometry, cytogenetics/FISH, Immunohistochemistry, Cellsearch Circulating Tumor Cell (CTC & CEC) analysis, cell culture, anatomic pathology, toxicology and routine biochemistry.Geneuity is a division of Molecular Pathology Laboratory Network, Inc. (MPLN), a privately held molecular diagnostic laboratory in business for over 20 years. Geneuity & MPLN are GLP compliant, certified under Clinical Laboratory Improvement Amendments (CLIA), accredited by the College of American Pathologists (CAP) and licensed by the states of NY, FL, TN and MD.